Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis - PubMed (original) (raw)
. 1997 Jun 1;57(11):2295-303.
Affiliations
- PMID: 9187135
Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis
S Xie et al. Cancer Res. 1997.
Abstract
The cell surface adhesion molecule MCAM (MUC18) is strongly expressed by advanced primary and metastatic melanomas but is weaker and less frequent in nevus cells. Previous studies have shown that MCAM expression correlates with tumor thickness and metastatic potential of human melanoma cells in nude mice. To provide direct evidence that MCAM plays a role in tumor growth and metastasis of human melanoma, the nonmetastatic MCAM-negative primary cutaneous melanoma SB-2 cells were transfected with MCAM cDNA and analyzed subsequently for changes in their tumorigenic and metastatic potential. Enforced expression of MCAM in SB-2 cells rendered them highly tumorigenic and increased their metastatic potential in nude mice as compared with parental and control transfected cells. The transfected cells displayed increased homotypic adhesion, increased attachment to human endothelial cells, decreased ability to adhere to laminin, and increased invasiveness through Matrigel-coated filters. Anti-MCAM monoclonal antibody reversed these functions in the transfected cells but not in control cells. The above changes in function attributed to the expression of MCAM may underlie the contribution of MCAM/MUC18 to the malignant phenotype.
Similar articles
- Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
Mills L, Tellez C, Huang S, Baker C, McCarty M, Green L, Gudas JM, Feng X, Bar-Eli M. Mills L, et al. Cancer Res. 2002 Sep 1;62(17):5106-14. Cancer Res. 2002. PMID: 12208768 - Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
Xie S, Price JE, Luca M, Jean D, Ronai Z, Bar-Eli M. Xie S, et al. Oncogene. 1997 Oct 23;15(17):2069-75. doi: 10.1038/sj.onc.1201358. Oncogene. 1997. PMID: 9366524 - A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo.
McGary EC, Heimberger A, Mills L, Weber K, Thomas GW, Shtivelband M, Lev DC, Bar-Eli M. McGary EC, et al. Clin Cancer Res. 2003 Dec 15;9(17):6560-6. Clin Cancer Res. 2003. PMID: 14695161 - Functional aspects of three molecules associated with metastasis development in human malignant melanoma.
Johnson JP, Lehmann JM, Stade BG, Rothbächer U, Sers C, Riethmüller G. Johnson JP, et al. Invasion Metastasis. 1989;9(6):338-50. Invasion Metastasis. 1989. PMID: 2574717 Review. - The role of CD146 (Mel-CAM) in biology and pathology.
Shih IM. Shih IM. J Pathol. 1999 Sep;189(1):4-11. doi: 10.1002/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P. J Pathol. 1999. PMID: 10451481 Review.
Cited by
- Melanoma cells homing to the brain: an in vitro model.
Rizzo A, Vasco C, Girgenti V, Fugnanesi V, Calatozzolo C, Canazza A, Salmaggi A, Rivoltini L, Morbin M, Ciusani E. Rizzo A, et al. Biomed Res Int. 2015;2015:476069. doi: 10.1155/2015/476069. Epub 2015 Jan 26. Biomed Res Int. 2015. PMID: 25692137 Free PMC article. - Therapeutic and Diagnostic Antibodies to CD146: Thirty Years of Research on Its Potential for Detection and Treatment of Tumors.
Stalin J, Nollet M, Dignat-George F, Bardin N, Blot-Chabaud M. Stalin J, et al. Antibodies (Basel). 2017 Nov 5;6(4):17. doi: 10.3390/antib6040017. Antibodies (Basel). 2017. PMID: 31548532 Free PMC article. Review. - Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis.
Melnikova VO, Balasubramanian K, Villares GJ, Dobroff AS, Zigler M, Wang H, Petersson F, Price JE, Schroit A, Prieto VG, Hung MC, Bar-Eli M. Melnikova VO, et al. J Biol Chem. 2009 Oct 16;284(42):28845-55. doi: 10.1074/jbc.M109.042150. Epub 2009 Aug 24. J Biol Chem. 2009. PMID: 19703903 Free PMC article. - Semaphorin 3A upregulates FOXO 3a-dependent MelCAM expression leading to attenuation of breast tumor growth and angiogenesis.
Mishra R, Thorat D, Soundararajan G, Pradhan SJ, Chakraborty G, Lohite K, Karnik S, Kundu GC. Mishra R, et al. Oncogene. 2015 Mar 19;34(12):1584-95. doi: 10.1038/onc.2014.79. Epub 2014 Apr 14. Oncogene. 2015. PMID: 24727891 - Pro- and anti-tumour activities of CD146/MCAM in breast cancer result from its heterogeneous expression and association with epithelial to mesenchymal transition.
Mannion AJ, Odell AF, Baker SM, Matthews LC, Jones PF, Cook GP. Mannion AJ, et al. Front Cell Dev Biol. 2023 Apr 17;11:1129015. doi: 10.3389/fcell.2023.1129015. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37138793 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical